AAAAAA

   
Results: 1-15 |
Results: 15
Amniotic fluid insulin at 14-20 weeks' gestation - Association with later maternal glucose intolerance and birth macrosomia
Authors: Carpenter, MW Canick, JA Hogan, JW Shellum, C Somers, M Star, JA
Citation: Mw. Carpenter et al., Amniotic fluid insulin at 14-20 weeks' gestation - Association with later maternal glucose intolerance and birth macrosomia, DIABET CARE, 24(7), 2001, pp. 1259-1263
Second-trimester levels of maternal serum human chorionic gonadotropin andinhibin A as predictors of preeclampsia in the third trimester of pregnancy
Authors: Lambert-Messerlian, GM Silver, HM Petraglia, F Luisi, S Pezzani, I Maybruck, WM Hogge, WA Hanley-Yanez, K Roberts, JM Neveux, LM Canick, JA
Citation: Gm. Lambert-messerlian et al., Second-trimester levels of maternal serum human chorionic gonadotropin andinhibin A as predictors of preeclampsia in the third trimester of pregnancy, J SOC GYN I, 7(3), 2000, pp. 170-174
Participation in maternal serum screening following screen positive results in a previous pregnancy
Authors: Rausch, DN Lambert-Messerlian, GM Canick, JA
Citation: Dn. Rausch et al., Participation in maternal serum screening following screen positive results in a previous pregnancy, J MED SCREE, 7(1), 2000, pp. 4-6
Second trimester levels of maternal serum inhibin A in pregnancies affected by fetal neural tube defects
Authors: Lambert-Messerlian, GM Palomaki, GE Canick, JA
Citation: Gm. Lambert-messerlian et al., Second trimester levels of maternal serum inhibin A in pregnancies affected by fetal neural tube defects, PRENAT DIAG, 20(8), 2000, pp. 680-682
High maternal serum inhibin A levels following the loss of one fetus in a twin pregnancy
Authors: Goodwin, KM Sweeney, PJ Lambert-Messerlian, GM Canick, JA
Citation: Km. Goodwin et al., High maternal serum inhibin A levels following the loss of one fetus in a twin pregnancy, PRENAT DIAG, 20(12), 2000, pp. 1015-1017
Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy
Authors: Rausch, DN Lambert-Messerlian, GM Canick, JA
Citation: Dn. Rausch et al., Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy, WEST J MED, 173(3), 2000, pp. 180-183
Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies
Authors: Phipps, MG Hogan, JW Peipert, JF Lambert-Messerlian, GM Canick, JA Seifer, DB
Citation: Mg. Phipps et al., Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies, OBSTET GYN, 95(2), 2000, pp. 227-231
First-trimester Down syndrome screening - Reply
Authors: Malone, FD D'Alton, ME Berkowitz, RL Canick, JA
Citation: Fd. Malone et al., First-trimester Down syndrome screening - Reply, AM J OBST G, 183(6), 2000, pp. 1591-1592
First-trimester screening for aneuploidy: Research or standard of care?
Authors: Malone, FD Berkowitz, RL Canick, JA D'Alton, ME
Citation: Fd. Malone et al., First-trimester screening for aneuploidy: Research or standard of care?, AM J OBST G, 182(3), 2000, pp. 490-496
Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening
Authors: Wald, NJ White, N Morris, JK Huttly, WJ Canick, JA
Citation: Nj. Wald et al., Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening, BR J OBST G, 106(12), 1999, pp. 1304-1306
Urinary analyte screening: a noninvasive detection method for Down syndrome?
Authors: Canick, JA Kellner, LH Cole, LA Cuckle, HS
Citation: Ja. Canick et al., Urinary analyte screening: a noninvasive detection method for Down syndrome?, MOL MED TOD, 5(2), 1999, pp. 68-73
Second-trimester maternal serum analyte levels associated with fetal trisomy 13
Authors: Saller, DN Canick, JA Blitzer, MG Palomaki, GE Schwartz, S Blakemore, KJ Haddow, JE
Citation: Dn. Saller et al., Second-trimester maternal serum analyte levels associated with fetal trisomy 13, PRENAT DIAG, 19(9), 1999, pp. 813-816
Second-trimester maternal serum progesterone levels in Turner syndrome with and without hydrops and in trisomy 18
Authors: Lambert-Messerlian, GM Saller, DN Tumber, MB French, CA Peterson, CJ Canick, JA
Citation: Gm. Lambert-messerlian et al., Second-trimester maternal serum progesterone levels in Turner syndrome with and without hydrops and in trisomy 18, PRENAT DIAG, 19(5), 1999, pp. 476-479
Collaborative study of maternal urine beta-core human chorionic gonadotrophin screening for Down syndrome
Authors: Cuckle, HS Canick, JA Kellner, LH
Citation: Hs. Cuckle et al., Collaborative study of maternal urine beta-core human chorionic gonadotrophin screening for Down syndrome, PRENAT DIAG, 19(10), 1999, pp. 911-917
Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies
Authors: Silver, HM Lambert-Messerlian, GM Star, JA Hogan, J Canick, JA
Citation: Hm. Silver et al., Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies, AM J OBST G, 180(5), 1999, pp. 1131-1137
Risultati: 1-15 |